Clinical Trials Sponsored by Circassia Limited

Total 2815 results

Circassia Limited

Completed

Phase III Cat-PAD Follow-on Study

Cat Allergy
Circassia Limited

Withdrawn

Efficacy and Safety of Grass-SPIRE Registration Study

Rhinitis | Conjunctivitis

United States
Circassia Limited

Completed

Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects

Cat Allergy

Canada
Circassia Limited

Completed

Safety of Cat-PAD in Cat Allergic Subjects

Cat Allergy

Germany
Circassia Limited
Quintiles, Inc.

Completed

Phase II HDM-SPIRE Safety and Efficacy Study

Rhinoconjunctivitis

United States, Germany, Spain, Canada, Netherlands, Italy, South Africa, France
Circassia Limited
Bioskin GmbH

Completed

Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Circassia Limited
Quintiles, Inc.

Completed

Ragweed Observational Study

Ragweed Allergy

United States
Circassia Limited
inVentiv Health Clinical

Completed

Paediatric Safety Study in Cat-PAD

Rhinoconjunctivitis

Poland
Circassia Limited
Syneos Health; CIDAL

Completed

Grass Observational Study

Grass Allergy | Rhinoconjunctivitis

United States, Argentina, Chile
Circassia Limited
Pharm-Olam International

Completed

House Dust Mite Observational Study

Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Ragweed-SPIRE Follow-On Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis

Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis

Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune House Dust Mite (HDM) Tolerability Study

Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis

Cat Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis

Allergy

Canada
Adiga Life Sciences, Inc.
Circassia Limited

Terminated

Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America

Allergy

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

Seasonal Allergic Rhinitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis

Cat Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma

Cat Allergy

Canada
Circassia Limited
inVentiv Health Clinical; Pharm-Olam International

Completed

Phase III Cat-PAD Study

Rhinoconjunctivitis

United States, Poland, Germany, Belgium, Canada, Russian Federation, Hungary, Slovakia, Czechia
Circassia Limited
Quintiles, Inc.; Adiga Life Sciences, Inc.

Completed

Birch-SPIRE Safety and Efficacy Study

Rhinitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Topstone Research

Completed

An Optional Investigation of Biomarkers of Efficacy

Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Exposure Unit Study

Grass Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis
Circassia Limited
Adiga Life Sciences, Inc.; Inflamax Research Incorporated

Completed

ToleroMune House Dust Mite Follow on Study

Rhinoconjunctivitis | House Dust Mite Allergy
Circassia Limited
Adiga Life Sciences, Inc.; Cetero Research, Toronto

Completed

An Optional Two Year Follow Up Study to Study CP005A

Cat Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Cat-PAD Exposure Chamber Study

Cat Allergy

Canada
National Institute of Allergy and Infectious Diseases...
Circassia Limited

Completed

A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Cat Allergy | Cat Hypersensitivity

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune House Dust Mites (HDM) Exposure Chamber Study

Rhinoconjunctivitis

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune Ragweed Exposure Chamber Study

Ragweed Allergy

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

Ragweed Allergy

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune Ragweed Follow up Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Cat-PAD Follow on Study

Cat Allergy | Rhinoconjunctivitis

Canada
Medaphor Limited
IntelligentUltrasound Limited

Completed

A Volunteer Study to Collect Imaging Data for the Development of the ntelligentUltrasound Anatomy Guide

Ultrasound Imaging of Anatomical Structures

United Kingdom
Heptares Therapeutics Limited
P1vital Limited

Completed

Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

Alzheimer's Disease

United Kingdom
pSiVida Limited
pSiOncology Private Limited

Unknown

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Liver Cancer

Singapore
Exonate Limited
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety and Tolerability of EXN407

Diabetic Macular Edema

Australia
SpyBiotech Limited

Recruiting

A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (SPYVAC01)

Cytomegalovirus Infections

United Kingdom
Medibio Limited

Recruiting

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) (SAMDE)

Depressive Disorder | Depression | Depressive Disorder, Major | Depressive Episode | Depression Mild

United States
CroiValve Limited

Recruiting

A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation (TANDEM I)

Tricuspid Regurgitation

Poland
Novoic Limited

Not yet recruiting

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping (EARS)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer's Disease (Incl Subtypes)
BicycleTx Limited

Recruiting

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Carcinoma, Non-Small-Cell Lung | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Ovarian Neoplasm | Urinary Bladder Neoplasm

United States, United Kingdom, France, Spain, Italy, Canada
BicycleTx Limited

Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Head and Neck Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Solid Tumor Historically Known for High EphA2 Expression | Urothelial Cancer | Gastric/Upper Gastrointestinal Cancer

United States, Belgium, Korea, Republic of, Spain, United Kingdom
Laekna Limited

Active, not recruiting

Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (PROFECTA-II)

Platinum-resistant Ovarian Cancer

United States, China
GenieBiome Limited

Completed

A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLD

Non-Alcoholic Fatty Liver Disease

Hong Kong
Laekna Limited

Suspended

A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer

Prostate Cancer Metastatic

China

Clinical Trials Sponsored by Circassia Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations